Stay updated with breaking news from Itreous Bleeding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Most patients with diabetic retinopathy who take the GLP-1 agonist semaglutide don't experience a worsening of the condition, a new study found, but they still require screening and follow-up.
Recalled in 2022, a port delivery system for ranibizumab to treat wet AMD demonstrated that vision and retinal anatomy remained stable in patients who had the device for 5 years.
The presence of diabetic foot ulcers may impede the care of retinopathy, researchers have found.
While a Korean study shows reduction in diabetic retinopathy progression by 11% with fenofibrate plus statin compared with statin alone, some reservations remain over wider use.
A treat-and-extend regimen of intravitreal aflibercept shows promise for stabilizing visual acuity in radiation retinopathy.